Financhill
Back

Ovid Therapeutics Stock Predictions

Ovid Therapeutics Stock Forecast

  • Is Ovid Therapeutics Stock Undervalued?
    The current Ovid Therapeutics [OVID] share price is $1.17. The Score for OVID is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • OVID is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Ovid Therapeutics Stock Go Up Next Year?

Data Unavailable

Ovid Therapeutics Stock Rating

Data Unavailable

Ovid Therapeutics Stock Price History

Is OVID stock going to rise?

  • The current trend is relatively stagnant and OVID is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ovidrx.com

52-Week Data

52-Week High:
4.10
52-Week Low:
0.68

Prediction Charts

Market Cap:
83.04M
Price in USD:
1.17
Volume:
92.35K
Beta:
0.83

Technical Analysis

SMA50:
1.06
SMA100:
1.71
SMA200:
2.51
52-Wk Change:
-69.61%

Stock Predictions

  • Is Ovid Therapeutics stock public?
    Yes, Ovid Therapeutics is a publicly traded company.
  • What is the Ovid Therapeutics stock quote today?
    The Ovid Therapeutics stock price is 1.17 USD today.
  • How to buy Ovid Therapeutics stock online?
    You can buy Ovid Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 1.20 1.13 1.24 1.07
Sep-3 1.11 1.09 1.12 1.07
Sep-4 1.11 1.09 1.11 0.99
Sep-5 1.10 1.14 1.14 1.09
Sep-6 1.11 1.02 1.12 0.96
Sep-9 1.00 1.07 1.09 0.98
Sep-10 1.08 1.11 1.13 1.04
Sep-11 1.10 1.13 1.13 1.05
Sep-12 1.10 1.11 1.13 1.09
Sep-13 1.13 1.19 1.19 1.11
Sep-16 1.20 1.17 1.20 1.13
Sep-17 1.20 1.12 1.20 1.11
Sep-18 1.13 1.06 1.15 1.03
Sep-19 1.11 1.17 1.17 1.06

Ovid Therapeutics Earnings

Data Unavailable

Ovid Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.23 per share.

* Ovid Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.